Importantly, this is a comprehensive study on METTL14 function in BlCa, with evaluation of its expression in 120 human patient samples and in eight distinct cell lines, in addition to assessment of phenotypic effects of its knockdown on both viability, apoptosis, migration, and invasion properties. Here, METTL14 is linked to bladder transitional cell carcinoma.